Legacy Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Legacy Trust's EW Position: Q3 2026 in Review
Legacy Trust increased its Edwards Lifesciences (EW) stake by 1.4% in Q3 2026, buying an estimated $9.24K and bringing the position to 7,409 shares worth $682K. The position accounts for 0.11% of the portfolio, ranked #121.
Legacy Trust first reported a position in EW in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.54M in Q1 2024. 774 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Legacy Trust held 7,409 shares of Edwards Lifesciences worth $682K as of Q3 2026.
- Legacy Trust bought 104 Edwards Lifesciences shares in Q3 2026, an estimated $9.24K.
- Edwards Lifesciences made up 0.11% of Legacy Trust's portfolio in Q3 2026, its #121 holding.
- Legacy Trust first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 16 quarters since.
- Legacy Trust's Edwards Lifesciences position peaked at $1.54M in Q1 2024.
- 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Legacy Trust's 13F filing for Q3 2026, filed 6 Nov 2026.